The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Role of Matrix β-1,3 Glucan in Antifungal Resistance of Non-albicans Candida Biofilms
Open accessAbstract
Candida biofilm infections pose an increasing threat in the health care setting due to the drug resistance associated with this lifestyle. Several mechanisms underlie the resistance phenomenon. In Candida albicans, one mechanism involves drug impedance by the biofilm matrix linked to β-1,3 glucan. Here, we show this is important for other Candida spp. We identified β-1,3 glucan in the matrix, found that the matrix sequesters antifungal drug, and enhanced antifungal susceptibility with matrix β-1,3 glucan hydrolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“C. glabrata biofilms display antifungal resistance, and are characterized by a compact dense structure of yeast cells nested in an extracellular matrix which is composed of high levels of proteins and carbohydrates including β-1,3 glucan [50,51,52].”
From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [52]
In the citing paper
“It is thought that biofilms prevent, to a greater or lesser extent, the penetration of antifungal drugs through their structure, by the establishment of a diffusion barrier, which acts as an ion-exchange resin, binding charged antibiotic molecules, contributing to biofilm drug resistance, including in the case of C. glabrata [44,150,155].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [155]
In the citing paper
“When induced, the disruption of β-1,3-glucans or a β-1,3-glucanase treatment have been shown to increase susceptibility of biofilms to fluconazole and the addition of exogenous β-1,3 glucans has been demonstrated to result in the rise of resistance to fluconazole in planktonic cells [155].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [155]
In the citing paper
“Thus, treatment of biofilms with β-1,3-glucanase increases the susceptibility of biofilms to fluconazole (130), and addition of exogenous β-1,3-glucans increases the tolerance of planktonic cells to fluconazole (122).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,296
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
Al-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Mukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4333-4340.2003 · Cited by 511
Cited by
Sorted by citations
The global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms
Acker, H. V., Dijck, P. V., & Coenye, T. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.02.001 · Cited by 546
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418
Echinocandin resistance in Candida.
Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374
Candida parapsilosis: from genes to the bedside
Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327
Mechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Fungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
Self-citationAntifungal drugs: What brings the future?
Daele, R. V., Spriet, I., Wauters, J., Maertens, J. A., Mercier, T., Hecke, S. V., & Brüggemann, R. J. M. (2019) · Medical Mycology · doi:10.1093/mmy/myz012 · Cited by 227
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 205
Community participation in biofilm matrix assembly and function
Mitchell, K. F., Zarnowski, R., Sanchez, H., Edward, J. A., Reinicke, E. L., Nett, J. E., Mitchell, A. P., & Andes, D. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421437112 · Cited by 183
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
Cui, J., Ren, B., Tong, Y., Dai, H., & Zhang, L. (2015) · Virulence · doi:10.1080/21505594.2015.1039885 · Cited by 178
Contributions of the Biofilm Matrix to Candida Pathogenesis
Nett, J. E., & Andes, D. R. (2020) · Journal of Fungi · doi:10.3390/jof6010021 · Cited by 164
The Interface between Fungal Biofilms and Innate Immunity
Kernien, J. F., Snarr, B. D., Sheppard, D. C., & Nett, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01968 · Cited by 158
Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Maubon, D., Garnaud, C., Calandra, T., Sanglard, D., & Cornet, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3404-7 · Cited by 141
Candida auris Infection and Biofilm Formation: Going Beyond the Surface
Horton, M. V., & Nett, J. E. (2020) · Current Clinical Microbiology Reports · doi:10.1007/s40588-020-00143-7 · Cited by 132
Fungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions
Mitchell, K. F., Zarnowski, R., & Andes, D. R. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005828 · Cited by 132
Candida glabrata Biofilms: How Far Have We Come?
Rodrigues, C., Rodrigues, M., Silva, S., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010011 · Cited by 129
Candida glabrata: A Lot More Than Meets the Eye
Kumar, K., Askari, F., Sahu, M. S., & Kaur, R. (2019) · Microorganisms · doi:10.3390/microorganisms7020039 · Cited by 128
Biofilm Exopolysaccharides of Pathogenic Fungi: Lessons from Bacteria
Sheppard, D. C., & Howell, P. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.720995 · Cited by 129
Review on Current Status of Echinocandins Use
Mroczyńska, M., & Brillowska‐Dąbrowska, A. (2020) · Antibiotics · doi:10.3390/antibiotics9050227 · Cited by 113
Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99
What We Do Not Know about Fungal Cell Adhesion Molecules
Lipke, P. N. (2018) · Journal of Fungi · doi:10.3390/jof4020059 · Cited by 99
The Extracellular Matrix of Fungal Biofilms
Mitchell, K. F., Żarnowski, R., & Andes, D. R. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_6 · Cited by 93
Future directions for anti-biofilm therapeutics targetingCandida
Nett, J. E. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.885838 · Cited by 80
Combination Therapy to Treat Fungal Biofilm-Based Infections
Tits, J., Cammue, B. P. A., & Thevissen, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228873 · Cited by 71
Fungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 69
A common vesicle proteome drives fungal biofilm development
Zarnowski, R., Sanchez, H., Jaromin, A., Zarnowska, U. J., Nett, J. E., Mitchell, A. P., & Andes, D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211424119 · Cited by 63
Self-citationBorah, S. N., Sen, S., Goswami, L., Bora, A., Pakshirajan, K., & Deka, S. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110358 · Cited by 62
Phloroglucinol and Its Derivatives: Antimicrobial Properties toward Microbial Pathogens
Khan, F., Tabassum, N., Bamunuarachchi, N. I., & Kim, Y. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00532 · Cited by 59
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 58
Role of Exopolysaccharides in Biofilm Formation
Gupta, P., Pruthi, P. A., & Pruthi, V. (2019) · ACS symposium series · doi:10.1021/bk-2019-1323.ch002 · Cited by 55
Vila, T. V. M., Ishida, K., Seabra, S. H., & Rozental, S. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.07.022 · Cited by 52
Dehullu, J., Valotteau, C., Herman-Bausier, P., Garcia-Sherman, M. C., Mittelviefhaus, M., Vorholt, J., Lipke, P., & Dufrêne, Y. (2019) · Nano letters (Print) · doi:10.1021/acs.nanolett.9b01010 · Cited by 46
Pannanusorn, S., Ramı́rez-Zavala, B., Lünsdorf, H., Agerberth, B., Morschhäuser, J., & Römling, U. (2013) · Eukaryotic Cell · doi:10.1128/ec.00181-13 · Cited by 51
Zinc oxide nanoparticles hinder fungal biofilm development in an ancient Egyptian tomb
Gambino, M., Ahmed, M. A., Villa, F., & Cappitelli, F. (2017) · International Biodeterioration & Biodegradation · doi:10.1016/j.ibiod.2017.05.011 · Cited by 48
Rodrigues, C. F., & Henriques, M. (2017) · Pathogens · doi:10.3390/pathogens6040062 · Cited by 48
Role of the extracellular matrix in Candida biofilm antifungal resistance
Massey, J., Żarnowski, R., & Andes, D. R. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad059 · Cited by 47
Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase
Bojsen, R. K., Regenberg, B., & Folkesson, A. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0305-4 · Cited by 47
Tan, Y., Leonhard, M., Moser, D., & Schneider‐Stickler, B. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.04.101 · Cited by 39
Tan, Y., Ma, S., Leonhard, M., Moser, D., & Schneider‐Stickler, B. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.003 · Cited by 37
Panariello, B. H. D., Klein, M. I., Mima, E. G. D. O., & Pavarina, A. C. (2018) · Journal of Oral Microbiology · doi:10.1080/20002297.2018.1476644 · Cited by 37
Chandra, J., & Ghannoum, M. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01750-17 · Cited by 36
Manfiolli, A. O., dos Reis, T. F., de Assis, L. J., de Castro, P. A., Silva, L. P., Hori, J. I., Walker, L. A., Munro, C. A., Rajendran, R., Ramage, G., et al. (2018) · The Cell Surface · doi:10.1016/j.tcsw.2018.03.002 · Cited by 36
Shi, C., Liu, J., Li, W., Zhao, Y., Meng, L.-N., & Xiang, M.-J. (2019) · Brazilian Journal of Microbiology · doi:10.1007/s42770-018-0009-2 · Cited by 30
The role of the Candida biofilm matrix in drug and immune protection
Roy, S., & Gow, N. A. R. (2023) · The Cell Surface · doi:10.1016/j.tcsw.2023.100111 · Cited by 33
Raman, N., Lee, M., Lynn, D. M., & Palecek, S. P. (2015) · Pharmaceuticals · doi:10.3390/ph8030483 · Cited by 28
Adhesion and biofilm formation by the opportunistic pathogen Candida tropicalis: what do we know?
de Souza, C. M., dos Santos, M. M., Furlaneto-Maia, L., & Furlaneto, M. C. (2023) · Canadian Journal of Microbiology · doi:10.1139/cjm-2022-0195 · Cited by 39
Madariaga, F., Fernández-Soto, R., Duarte, L. F., Suarez, N., Delgadillo, D., Jara, J. A., Fernández‐Ramires, R., Urzúa, B., & Molina‐Berríos, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176755 · Cited by 26
Future therapies targeted towards eliminatingCandidabiofilms and associated infections
Bandara, N., Matsubara, V. H., & Samaranayake, L. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268530 · Cited by 29
Singh, R., Kumari, A., Kaur, K., Sethi, P., & Chakrabarti, A. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000757 · Cited by 26
Karkowska‐Kuleta, J., Kulig, K., Braś, G., Stelmaszczyk, K., Surowiec, M., Kozik, A., Karnas, E., Woźnicka, O., Zuba‐Surma, E. K., Pyza, E., et al. (2023) · Journal of Fungi · doi:10.3390/jof9111078 · Cited by 22
Tetz, G. V., Collins, M. S., Vikina, D., & Tetz, V. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01975-18 · Cited by 23
Antifungal Properties of Cationic Phenylene Ethynylenes and Their Impact on β-Glucan Exposure
Pappas, H. C., Sylejmani, R., Graus, M. S., Donabedian, P. L., Whitten, D. G., & Neumann, A. K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00317-16 · Cited by 22
Da, W., Shao, J., Li, Q., Shi, G., Wang, T., Wu, D., & Wang, C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00034 · Cited by 22
Zainab, S., Hamid, S., Sahar, S., & Ali, N. (2021) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2021.125451 · Cited by 25
Learning the ABC of oral fungal drug resistance
Cannon, R. D., & Holmes, A. R. (2015) · Molecular Oral Microbiology · doi:10.1111/omi.12109 · Cited by 20
Assembly and Antifungal Effect of a New Fluconazole-Carrier Nanosystem
de Lima, T. M., Arias, L. S., Afanaci, L. F., Rf, B. F., Neto, F. N. D. S., de Lima, B. H. R., Straioto, F. G., Camargo, E. R., Pessan, J. P., & Monteiro, D. R. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0182 · Cited by 20
Marcos-Zambrano, L. J., Escribano, P., Bouza, E., & Guinea, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw162 · Cited by 19
Chang, D. H., Lee, M., Wang, N., Lynn, D. M., & Palecek, S. P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00468 · Cited by 20
Neubauer, D., Jaśkiewicz, M., Bauer, M., Olejniczak-Kęder, A., Sikorska, E., Sikora, K., & Kamysz, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073299 · Cited by 22
Candida auris biofilm: a review on model to mechanism conservation
Khari, A., Biswas, B., Gangwar, G., Thakur, A., & Puria, R. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2179036 · Cited by 18
Liu, H., Liu, B., Zheng, F., Chen, X., Ye, L., & He, Y. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-928 · Cited by 18
Miyake, A., Gotoh, K., Iwahashi, J., Togo, A., Horita, R., Miura, M., Kinoshita, M., Ohta, K., Yamashita, Y., & Watanabe, H. (2022) · Journal of Fungi · doi:10.3390/jof8070700 · Cited by 20
Brilhante, R. S. N., Vago, P. B., Castelo‐Branco, D. D. S. C. M., Guedes, G. M. D. M., de Oliveira, J. S., de Alencar, L. P., Cordeiro, R. D. A., Pinheiro, M. D. N. S. M., Nogueira‐Filho, E. F., Pereira‐Neto, W. D. A., et al. (2017) · Veterinary Ophthalmology · doi:10.1111/vop.12465 · Cited by 16
Dispersal of single and mixed non- albicans Candida species biofilms by β-1,3-glucanase in vitro
Tan, Y., Leonhard, M., Ma, S., Moser, D., & Schneider‐Stickler, B. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.10.057 · Cited by 16
Shao, J., Lu, K.-Q., Tian, G., Cui, Y., Yan, Y., Wang, T., Zhang, X., & Wang, C. (2014) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2014.12.006 · Cited by 14
Candida Biofilm Tolerance: Comparison of Planktonic and Biofilm Resistance Mechanisms
Dominguez, E. G., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_6 · Cited by 14
Removal of a Model Biofilm by Sophorolipid Solutions: A QCM-D Study
Kaga, H., Nakamura, A., Orita, M., Endo, K., Akamatsu, M., Sakai, K., & Sakai, H. (2022) · Journal of Oleo Science · doi:10.5650/jos.ess21360 · Cited by 13
Hydrogen peroxide enhances the efficacy of photodynamic therapy against Candida albicans biofilms
de Sousa, T. V., Jordão, C. C., Abreu‐Pereira, C. A., Pereira, A. L. G., Barbugli, P. A., Klein, M. I., & Pavarina, A. C. (2023) · Biofouling · doi:10.1080/08927014.2023.2189011 · Cited by 15
Pesee, S., Angkananuwat, C., Tancharoensukjit, S., Muanmai, S., Sirivan, P., Bubphawas, M., & Tanarerkchai, N. (2016) · Medical Mycology · doi:10.1093/mmy/myv108 · Cited by 15
Exopolysaccharides and Biofilms
Mauff, F. L. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_199 · Cited by 13
Mendoza, S. R., Liedke, S. C., Noval, C., Ferreira, M. D. S., Gomes, K. X., Honorato, L., Nimrichter, L., Peralta, J. M., & Guimaraes, A. J. (2022) · Medical Mycology · doi:10.1093/mmy/myac050 · Cited by 9
Tuan, D. A., & Masák, J. (2026) · Current Microbiology · doi:10.1007/s00284-025-04713-0 · Cited by 10
Kumar, S., Jacob, J., Reshma, U. R., Rajesh, R. O., & Kumar, B. S. D. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01167 · Cited by 8
RetractedGaining More Insight into the Determinants of Candida Species Pathogenicity in the Oral Cavity
Arzmi, M. H., AlShwaimi, E., Himratul-Aznita, W. H., Razak, F. B. A., Farina, F., McCullough, M. J., & Cirillo, N. (2014) · European Journal of Inflammation · doi:10.1177/1721727x1401200202 · Cited by 8
In vitro antimicrobial effects of chitosan on microcosm biofilms of oral candidiasis
Araujo, H. C., Carmona, W. R., Sato, C., Oliveira, M. J. D. S., Alves, G. D. S. G., Morato, D. N., Pessan, J. P., & Monteiro, D. R. (2022) · Journal of Dentistry · doi:10.1016/j.jdent.2022.104246 · Cited by 7
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 7
Exploring antimicrobial properties of cholesterol esters: a systematic literature review
Jong, T., & Mudgil, P. (2022) · All Life · doi:10.1080/26895293.2022.2085816 · Cited by 6
Fattouh, N., Husni, R., Finianos, M., Bitar, I., & Khalaf, R. A. (2024) · Mycoses · doi:10.1111/myc.13750 · Cited by 5
Yeast Biofilms in the Context of Human Health and Disease
Raut, J. S., Doke, S. K., & Karuppayil, S. M. (2017) · Springer eBooks · doi:10.1007/978-981-10-2621-8_6 · Cited by 6
de Souza, C. M., Paulo, E. A., de Souza, N. A. A., dos Santos, M. M., Mantovani, M. S., Furlaneto-Maia, L., & Furlaneto, M. C. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107807 · Cited by 4
Abreu‐Pereira, C. A., Pereira, A. L. G., Jordão, C. C., Paro, C. B., Barbugli, P. A., & Pavarina, A. C. (2025) · Journal of Dentistry · doi:10.1016/j.jdent.2025.105631 · Cited by 4
Candida Biofilm: Clinical Implications of Recent Advances in Research
Press, E. G., Shields, R. K., & Clancy, C. J. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0176-z · Cited by 4
Contributions of Extracellular Vesicles to Fungal Biofilm Pathogenesis
Heredia, M. Y., & Andes, D. R. (2021) · Current topics in microbiology and immunology · doi:10.1007/978-3-030-83391-6_7 · Cited by 3
The Role of Biofilm Matrix in Mediating Antifungal Resistance
Nett, J. E., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_20 · Cited by 3
Shi, J., Lan, N., Zeng, F., Liu, N., Xue, C., & Yang, B. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1774864 · Cited by 2
Achilonu, C. C. (2026) · Drugs and Drug Candidates · doi:10.3390/ddc5030047 · Cited by 2
Interaction between Sophorolipids and β-glucan in Aqueous Solutions
Kaga, H., Orita, M., Endo, K., Akamatsu, M., Sakai, K., & Sakai, H. (2024) · Journal of Oleo Science · doi:10.5650/jos.ess23189 · Cited by 2
Genoma de Candida albicans y resistencia a las drogas
Quintana, S. M. C., Sjostrom, P. D., Baldeón, G. M. M., Socarrás, D. A., Paz, M. M. C., & Molina, A. H. (2017) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Capoor, M. R., & Bal, A. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00211-5 · Cited by 2
Strategien bei Versagen einer antimykotischen Therapie auf Intensivstation
Arens, C., Bernhard, M., Koch, C., Heininger, A., Störzinger, D., Hoppe‐Tichy, T., Hecker, M., Grabein, B., Weigand, M. A., & Lichtenstern, C. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0072-0 · Cited by 1
The Role of Biofilm Matrix in Mediating Antifungal Resistance
Nett, J. E., & Andes, D. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_20-1 · Cited by 1
Host-Induced Stress Response in Human Pathogenic Fungi
Viana, R., Pais, P., Cavalheiro, M., Galocha, M., & Teixeira, M. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819990-9.00035-4 · Cited by 1
Perlin, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_29
Pratiwi, R. H., Sulistyaniningsih, E., & Jepri, J. (2024) · Jurnal Biodjati · doi:10.15575/biodjati.v9i1.32147
Dissemination of Candida auris Biofilms: A Medical Abrosia
Gangwar, G., Singh, B., & Puria, R. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_10
Composition and Role of the Extracellular Matrix in Fungal Biofilm Drug Resistance
Kim, M.-J., Żarnowski, R., & Andes, D. R. (2025) · Springer series on biofilms · doi:10.1007/978-3-031-93315-8_8
Metadata
- Authors
- Mitchell, K. F., Taff, H. T., Cuevas, M. A., Reinicke, E. L., Sanchez, H., & Andes, D. R.
- Affiliations
- University of Wisconsin–Madison (US)
- University of Puerto Rico at Cayey (PR)
- University of Wisconsin, Madison, Wisconsin, USA
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-04
- Volume
- 57
- Issue
- 4
- Pages
- 1918-1920
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3623361
- OpenAlex
- W2122010658
- Cited by
- 104
- References
- 24
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 7 · 2019: 9 · 2018: 5 · 2017: 15 · 2016: 10 · 2015: 11 · 2014: 10 · 2013: 4
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (T32GM008692)
- National Institute of Allergy and Infectious Diseases (NIH R01 AI073289-01, R01AI073289)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- β-1,3-glucan, Candida biofilms, non-albicans Candida, antifungal resistance, biofilm matrix, antifungal susceptibility, glucan hydrolysis
- MeSH terms
- Antifungal Agents, Candida albicans, Proteoglycans, Biofilms, Drug Resistance, Fungal, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review